Back to
Walleye Capital LLC
JAZZ20 quarters
Position history for
Walleye Capital LLC's holdings in JAZZ PHARMACEUTICALS PLC
No. Walleye Capital exited its JAZZ (Jazz Pharmaceuticals) position in Q2 2026. Its Q1 2026 13F listed 87,365 shares worth $16.5M. Walleye Capital first reported JAZZ in Q1 2019 and held it in 15 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$456,000
Total Shares Change
-3,184
Quarter-by-Quarter History
Other major holders of JAZZ: BlackRock, Inc., FMR LLC, VANGUARD GROUP INC